跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHEBRA NAPROXEN SUSPENSION naproxen 125mg/5mL oral liquid bottle - TGA Drug Approval Details
Approvals
/
TGA
/
PHEBRA NAPROXEN SUSPENSION naproxen 125mg/5mL oral liquid bottle
Approved
STANDARD
PHEBRA NAPROXEN SUSPENSION naproxen 125mg/5mL oral liquid bottle
Phebra Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
04db35355c3c58f2
Company
Phebra Pty Ltd
Type
Standard
Approval Details
Approval Id
04db35355c3c58f2
Product Name
PHEBRA NAPROXEN SUSPENSION naproxen 125mg/5mL oral liquid bottle
Artg Id
196596
Artg Name
PHEBRA NAPROXEN SUSPENSION naproxen 125mg/5mL oral liquid bottle
Sponsor
Phebra Pty Ltd
Company Detail Path
/organization/phebra-pty-ltd
Artg Date
2012-06-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/2c2270482d1be8c6d297b1e471331a7d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/df2e187cae440a459111d0dea3ce7586.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
04db35355c3c58f2
Type
Standard
Back to TGA Approvals